The Selective SMARCA2 Degrader, PRT3789, Counteracts the Protective Cellular Stress Response to Chemotherapy and Enhances the Efficacy of Standard of Care Chemotherapeutic Agents in SMARCA4 Mutant NSCLC Models

Michael Hulse, Jessica Burtell, Komali Vykuntam, Sang Hyun Lee, Peggy Scherle and Koichi Ito